Safety of an Abbreviated Duration of Dual Antiplatelet Therapy (≤ Six Months) Following Second-Generation Drug-Eluting Stents for Coronary Artery Disease: A Systematic Review and M...

Tekijä Ziada, Khaled M., Abdel-Latif, Ahmed K., Charnigo, Richard, Moliterno, David J.
Julkaisussa Catheter Cardiovasc Interv (2015)

Cardiac amyloidosis

Tekijä Salah, Ali K, Ahmed, Agha, Bodiwala, Kunal N, Manaloor, Elizabeth J, Thornton, John W, Moliterno, David J
Julkaistu 2008

Reduction in Overall Occurrences of Ischemic Events With Vorapaxar: Results From TRACER

Tekijä White, Harvey D., Huang, Zhen, Tricoci, Pierluigi, Van de Werf, Frans, Wallentin, Lars, Lokhnygina, Yuliya, Moliterno, David J., Aylward, Philip E., Mahaffey, Kenneth W., Armstrong, Paul W.
Julkaisussa J Am Heart Assoc (2014)

Premature Myocardial Infarction Novel Susceptibility Locus on Chromosome 1P34-36 Identified by Genomewide Linkage Analysis

Tekijä Wang, Qing, Rao, Shaoqi, Shen, Gong-Qing, Li, Lin, Moliterno, David J., Newby, L. Kristin, Rogers, William J., Cannata, Ruth, Zirzow, Erich, Elston, Robert C., Topol, Eric J.
Julkaistu 2004

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non‐ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

Tekijä Hernández, Adrián V, Westerhout, Cynthia M, Steyerberg, Ewout W, Ioannidis, John P A, Bueno, Héctor, White, Harvey, Theroux, Pierre, Moliterno, David J, Armstrong, Paul W, Califf, Robert M, Wallentin, Lars C, Simoons, Maarten L, Boersma, Eric
Julkaistu 2007

Ei nimekettä

Tekijä Hernandez, Adrian V, Westerhout, Cynthia M, Steyerberg, Ewout W, Ioannidis, John P A, Bueno, Hector, White, Harvey, Theroux, Pierre, Moliterno, David J, Armstrong, Paul W, Califf, Robert M, Wallentin, Lars C, Simoons, Maarten L, Boersma, Eric
Julkaistu 2007

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acut...

Tekijä Valgimigli, Marco, Costa, Francesco, Lokhnygina, Yuliya, Clare, Robert M., Wallentin, Lars, Moliterno, David J., Armstrong, Paul W., White, Harvey D., Held, Claes, Aylward, Philip E., Van de Werf, Frans, Harrington, Robert A., Mahaffey, Kenneth W., Tricoci, Pierluigi
Julkaisussa Eur Heart J (2017)

Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

Tekijä van Diepen, Sean, Tricoci, Pierluigi, Podder, Mohua, Westerhout, Cynthia M., Aylward, Philip E., Held, Claes, Van de Werf, Frans, Strony, John, Wallentin, Lars, Moliterno, David J., White, Harvey D., Mahaffey, Kenneth W., Harrington, Robert A., Armstrong, Paul W.
Julkaisussa J Am Heart Assoc (2015)

Discharge timing and outcomes after uncomplicated non–ST-segment elevation acute myocardial infarction

Tekijä Rymer, Jennifer A., Tempelhof, Michael W., Clare, Robert M., Pieper, Karen S., Granger, Christopher B., Van de Werf, Frans, Moliterno, David J., Harrington, Robert A., White, Harvey D., Armstrong, Paul W., Lopes, Renato D., Mahaffey, Kenneth W., Newby, L. Kristin
Julkaisussa Am Heart J (2018)

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

Tekijä Ungar, Leo, Clare, Robert M., Rodriguez, Fatima, Kolls, Bradley J., Armstrong, Paul W., Aylward, Philip, Held, Claes, Moliterno, David J., Strony, John, Van de Werf, Frans, Wallentin, Lars, White, Harvey D., Tricoci, Pierluigi, Harrington, Robert A., Mahaffey, Kenneth W., Melloni, Chiara
Julkaisussa J Am Heart Assoc (2018)

Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non–ST-Segment Elevation Acute Coronary Syndrome Patients: Insights from Clinical Trials...

Tekijä Kragholm, Kristian, Halim, Sharif A., Yang, Qinghong, Schulte, Phillip J., Hochman, Judith S., Melloni, Chiara, Mahaffey, Kenneth W., Moliterno, David J., Harrington, Robert A., White, Harvey D., Armstrong, Paul W., Ohman, E. Magnus, Van de Werf, Frans, Tricoci, Pierluigi, Alexander, John H., Giugliano, Robert P., Newby, L. Kristin
Julkaisussa Circ Cardiovasc Qual Outcomes (2015)

Effects of Genetic Variation in Protease Activated Receptor 4 after an Acute Coronary Syndrome: Analysis from the TRACER trial

Tekijä Tricoci, Pierluigi, Neely, Megan, Whitley, Michael J., Edelstein, Leonard C., Simon, Lukas M., Shaw, Chad, Fortina, Paolo, Moliterno, David J., Armstrong, Paul W., Aylward, Philip, White, Harvey, Van de Werf, Frans, Jennings, Lisa K., Wallentin, Lars, Held, Claes, Harrington, Robert A, Mahaffey, Kenneth W., Bray, Paul F.
Julkaisussa Blood Cells Mol Dis (2018)

QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study

Tekijä Whitbeck, Matthew G., Charnigo, Richard J., Shah, Jignesh, Morales, Gustavo, Leung, Steve W., Fornwalt, Brandon, Bailey, Alison L., Ziada, Khaled, Sorrell, Vincent L., Zegarra, Milagros M., Thompson, Jenks, Hosn, Neil Aboul, Campbell, Charles L., Gurley, John, Anaya, Paul, Booth, David C., Biase, Luigi Di, Natale, Andrea, Smyth, Susan, Moliterno, David J., Elayi, Claude S.
Julkaisussa Europace (2014)